Becker's Healthcare January 28, 2025
Patsy Newitt

Walgreens Boots Alliance’s prospective sale to a private equity firm is “mostly dead,” sources told CNBC’s David Faber, according to a Jan. 27 report from The Wall Street Journal.

Here are five things to know:

1. In December, the Journal reported that Walgreens could sell itself to private equity firm Sycamore Partners and become private in 2025.

2. According to the Journal, the deal was complicated by a lawsuit filed by the Justice Department on Jan. 16 alleging Walgreens and its subsidiaries unlawfully dispensed millions of prescriptions in violation of the Controlled Substances Act.

3. The news follows clinic closures across multiple states in 2025. In October, Walgreens announced in its fiscal fourth-quarter...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Investments, Pharma, Pharma / Biotech, Provider, Trends
From discovery to delivery: Finding an investment edge in biopharma services
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
Healthcare’s outlook in 2025: New administration spells uncertainty, but hope remains
World's most admired healthcare companies: Fortune
Trump Executive Order Signals Drug Pricing Reforms Likely on the Horizon

Share This Article